Table 3. A matrix of p-values between hospitalized patients’ demographics, symptoms, medical history, length of hospital stay and time from diagnosis to definitive outcome.
Variables | Length of hospital stay | Time from diagn. to outc. |
---|---|---|
Age | < 0.001 | < 0.001 |
Sex | 0.5 | 0.2 |
Race | < 0.001 | < 0.001 |
Symptoms | ||
Sore throat | 0.4 | 0.1 |
Shortness of breath | < 0.001 | < 0.001 |
Fever | 0.3 | 0.3 |
Cough | 0.6 | 0.02 |
Comorbidities | ||
Diabetes | 0.4 | 0.1 |
Immunosuppression | 1 | 0.3 |
Chronic kidney disease | 0.9 | 0.8 |
Chronic respiratory disease | 0.07 | 0.2 |
Cardiovascular disease | 0.4 | 0.2 |
Chromosomal disorder | 0.5 | 0.2 |
Others | ||
Low-risk pregnancy | 0.001 | 0.02 |
High-risk pregnancy | 0.3 | 0.3 |
Length of hospital stay | < 0.001 | < 0.001 |
Time from diagn. to outc. | < 0.001 | < 0.001 |
Pearson correlation was used to estimate p-values for age, length of hospital stay and time from diagnosis to definitive outcome variables. Age is reported in years. Length of hospital stay and time from diagnosis to definitive outcome are reported in days. The remaining p-values were estimated using one-way ANOVA. Immunosuppression may refer to a patient with HIV infection or autoimmune disease. Bold p-values indicate statistically significant p-values lower than 0.05. “Time from diagn. to outc.” is an abbreviation for “Time from diagnosis to definitive outcome”.